(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -38.59%-668K | 43.01%-929K | -42.49%1.29M | 118.23%710K | -47.50%577K | -310.48%-482K | 28.29%-1.63M | 176.13%2.25M | -1,083.59%-3.89M | 385.45%1.1M |
Net income from continuing operations | 99.69%-7K | -556.18%-13.97M | 13.92%-1.5M | -77.84%-15.66M | -1,594.98%-9.52M | -18.72%-2.26M | 27.01%-2.13M | 62.21%-1.75M | 58.05%-8.81M | 105.04%637K |
Operating gains losses | -178.98%-139K | -13,681.48%-3.72M | 135.19%57K | -144.97%-210K | 70.94%-197K | -67.23%176K | -106.04%-27K | -200.62%-162K | 211.33%467K | ---678K |
Depreciation and amortization | -53.99%623K | -12.52%1.22M | -5.87%1.32M | 6.89%5.51M | 17.74%1.37M | -7.95%1.35M | 5.14%1.39M | 16.51%1.4M | 124.53%5.15M | 65.62%1.16M |
Asset impairment expenditure | --0 | ---- | ---- | --10M | --10M | --0 | ---- | ---- | --0 | ---- |
Unrealized gains and losses of investment securities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -99.86%9K | ---- |
Remuneration paid in stock | -95.79%4K | -89.34%13K | -76.92%36K | -76.20%477K | -63.89%104K | -78.26%95K | -74.74%122K | -80.40%156K | -79.34%2M | -97.02%288K |
Deferred tax | -62.47%-723K | 307.60%355K | 177.12%273K | 50.95%-1.11M | 89.77%-144K | -47.84%-445K | 51.14%-171K | -66.98%-354K | -163.46%-2.27M | -209.45%-1.41M |
Other non cashItems | -41.73%-377K | -159.53%-178K | 840.63%903K | -246.71%-3.03M | -9,202.94%-3.16M | -263.19%-266K | 76.92%299K | -94.58%96K | 122.37%2.07M | -107.05%-34K |
Change In working capital | -105.65%-49K | 31.51%-763K | -92.65%210K | 288.52%4.75M | 89.77%2.13M | 607.60%868K | 21.44%-1.11M | 239.28%2.86M | -215.41%-2.52M | 613.24%1.12M |
-Change in receivables | -64.40%481K | 89.19%-4K | -112.91%-233K | 248.58%2.88M | -133.20%-244K | 2,902.22%1.35M | 96.88%-37K | 217.97%1.81M | -3,125.00%-1.94M | 234.09%735K |
-Change in prepaid assets | -231.11%-295K | -54.93%137K | 28.29%-436K | -4.10%491K | 271.69%570K | 268.85%225K | -29.95%304K | -274.21%-608K | 176.42%512K | 30.54%-332K |
-Change in payables and accrued expense | 4.79%525K | 60.09%-692K | -88.52%89K | 154.50%1.42M | 1,636.11%1.88M | -18.27%501K | -11.80%-1.73M | 143.79%775K | -176.45%-2.6M | -86.97%108K |
-Change in other current liabilities | --0 | --0 | ---2K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
-Change in other working capital | 37.14%-760K | -157.79%-204K | -10.61%792K | -102.52%-38K | -111.15%-68K | -36.46%-1.21M | -60.16%353K | -1.12%886K | 406.72%1.51M | 177.22%610K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -38.59%-668K | 43.01%-929K | -42.49%1.29M | 118.23%710K | -47.50%577K | -310.48%-482K | 28.29%-1.63M | 176.13%2.25M | -1,083.59%-3.89M | 385.45%1.1M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 844.26%454K | 992.90%4.03M | 80.00%-9K | 97.13%-564K | 97.71%-7K | -390.48%-61K | 92.80%-451K | 99.66%-45K | 37.35%-19.65M | -141.69%-306K |
Net PPE purchase and sale | 78.69%-13K | 97.56%-11K | 80.00%-9K | -587.80%-564K | 78.79%-7K | -390.48%-61K | -948.84%-451K | -66.67%-45K | -43.86%-82K | -94.12%-33K |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 37.50%-19.57M | -136.35%-273K |
Net other investing changes | --467K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 844.26%454K | 992.90%4.03M | 80.00%-9K | 97.13%-564K | 97.71%-7K | -390.48%-61K | 92.80%-451K | 99.66%-45K | 37.35%-19.65M | -141.69%-306K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 104.08%29K | -140.75%-3.2M | 13.37%-901K | -115.65%-4.37M | -30.86%-1.29M | 37.61%-710K | -110.22%-1.33M | -106.11%-1.04M | -12.70%27.9M | 27.21%-982K |
Net issuance payments of debt | 104.08%29K | -140.75%-3.2M | 17.88%-854K | -176.12%-4.37M | -30.86%-1.29M | 37.61%-710K | -110.22%-1.33M | 79.83%-1.04M | -38.13%5.73M | 27.69%-982K |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -0.41%22.8M | --0 |
Cash dividends paid | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -410.14%-1.06M | --0 |
Net other financing activities | --0 | --0 | ---47K | ---- | ---- | ---- | ---- | ---- | 4,644.44%427K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 104.08%29K | -140.75%-3.2M | 13.37%-901K | -115.65%-4.37M | -30.86%-1.29M | 37.61%-710K | -110.22%-1.33M | -106.11%-1.04M | -12.70%27.9M | 27.21%-982K |
Net cash flow | ||||||||||
Beginning cash position | -62.13%1.2M | -76.38%1.51M | -75.97%1.28M | 215.16%5.32M | -69.21%1.72M | -52.50%3.18M | 136.22%6.41M | 215.16%5.32M | 20.04%1.69M | 94.31%5.6M |
Current changes in cash | 85.24%-185K | 96.95%-104K | -67.16%381K | -196.92%-4.22M | -278.31%-715K | -41.10%-1.25M | -176.24%-3.41M | 21.34%1.16M | 1,580.69%4.35M | 81.10%-189K |
Effect of exchange rate changes | 1.50%-197K | -216.95%-207K | -102.78%-146K | 124.34%175K | 406.82%270K | 0.50%-200K | 135.47%177K | -204.35%-72K | -3,226.09%-719K | 54.40%-88K |
End cash Position | -52.38%821K | -62.13%1.2M | -76.38%1.51M | -75.97%1.28M | -75.97%1.28M | -69.21%1.72M | -52.50%3.18M | 136.22%6.41M | 215.16%5.32M | 215.16%5.32M |
Free cash from | -25.41%-681K | 54.83%-940K | -41.73%1.28M | 103.67%146K | -46.53%570K | -317.20%-543K | 10.15%-2.08M | 173.92%2.2M | -930.05%-3.98M | 365.17%1.07M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data